Market revenue in 2023 | USD 108.5 million |
Market revenue in 2030 | USD 181.9 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Biologics |
Fastest growing segment | Biologics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications |
Key market players worldwide | ConvaTec Group PLC, 3M Co, Coloplast A/S ADR, Smith & Nephew PLC, Medtronic PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetic foot ulcer treatment market will help companies and investors design strategic landscapes.
Biologics was the largest segment with a revenue share of 36.5% in 2023. Horizon Databook has segmented the Australia diabetic foot ulcer treatment market based on wound care dressings, biologics, therapy devices, antibiotic medications covering the revenue growth of each sub-segment from 2018 to 2030.
Australia depends majorly on the import of medical devices from countries including Japan and the U.S. The country’s medical device industry is governed by the TGA’s medical devices regulations. The market is mature and receptive toward new technologies resulting in faster adoption of advanced products.
This encourages major players to enter the Australian market, owing to which market growth is anticipated over the forecast period. Ongoing developments in medical technology, rising prevalence of diabetes disorders, aging population, growing income, and shifting consumer expectations are anticipated to boost the demand for medical applications, including diabetes devices, wound care dressings & devices, among all age groups.
Australians have one of the highest life expectancies in the world, ranking sixth among OECD nations. Rising investments by government organizations and market players in the country are expected to boost the demand for the raw materials required. Hence, several companies are launching innovative products and partnering with manufacturers to offer technologically advanced products.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia diabetic foot ulcer treatment market , including forecasts for subscribers. This country databook contains high-level insights into Australia diabetic foot ulcer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account